company background image
CALMA B logo

Calmark Sweden NGM:CALMA B Stock Report

Last Price

kr0.098

Market Cap

kr11.0m

7D

-2.9%

1Y

-80.5%

Updated

08 Mar, 2024

Data

Company Financials

Calmark Sweden AB (publ)

NGM:CALMA B Stock Report

Market Cap: kr11.0m

CALMA B Stock Overview

Calmark Sweden AB (publ) operates as a medical technology company in Sweden and internationally.

CALMA B fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Calmark Sweden AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Calmark Sweden
Historical stock prices
Current Share Pricekr0.098
52 Week Highkr1.10
52 Week Lowkr0.074
Beta1.49
1 Month Change-3.37%
3 Month Change-14.39%
1 Year Change-80.48%
3 Year Change-98.81%
5 Year Changen/a
Change since IPO-98.05%

Recent News & Updates

Recent updates

Shareholder Returns

CALMA BSE Medical EquipmentSE Market
7D-2.9%4.3%1.9%
1Y-80.5%-3.4%17.1%

Return vs Industry: CALMA B underperformed the Swedish Medical Equipment industry which returned -7.9% over the past year.

Return vs Market: CALMA B underperformed the Swedish Market which returned 6.9% over the past year.

Price Volatility

Is CALMA B's price volatile compared to industry and market?
CALMA B volatility
CALMA B Average Weekly Movement21.9%
Medical Equipment Industry Average Movement8.0%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.9%
10% least volatile stocks in SE Market3.4%

Stable Share Price: CALMA B's share price has been volatile over the past 3 months.

Volatility Over Time: CALMA B's weekly volatility (22%) has been stable over the past year, but is still higher than 75% of Swedish stocks.

About the Company

FoundedEmployeesCEOWebsite
20064Camilla Arnevinghttps://www.calmark.se

Calmark Sweden AB (publ) operates as a medical technology company in Sweden and internationally. The company manufactures and sells POC-Analyzer, a reader with a built-in software, analyzes the color change that occurs in the test cassette; and Neo-Bilirubin, a test cassette with a patented filter design that separates the red blood cells from the plasma used in the POC-Analyzer. It also provides a POC test solution for assessing the severity of COVID-19.

Calmark Sweden AB (publ) Fundamentals Summary

How do Calmark Sweden's earnings and revenue compare to its market cap?
CALMA B fundamental statistics
Market capkr11.03m
Earnings (TTM)-kr22.23m
Revenue (TTM)kr136.00k

81.1x

P/S Ratio

-0.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
CALMA B income statement (TTM)
Revenuekr136.00k
Cost of Revenuekr1.07m
Gross Profit-kr938.00k
Other Expenseskr21.30m
Earnings-kr22.23m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-0.20
Gross Margin-689.71%
Net Profit Margin-16,348.53%
Debt/Equity Ratio0%

How did CALMA B perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.